LAURA MARKWICK: Open Payments
NPI 1740363886 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,358 in 104 payments from 18 companies in 2025. Trend: 2023 $1,712 · 2024 $1,973 · 2025 $2,358
Food & beverage: $2,358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $459 |
| PFIZER INC. | 20 | $339 |
| Alexion Pharmaceuticals, Inc. | 10 | $277 |
| Phathom Pharmaceuticals, Inc. | 4 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $171 |
| Lundbeck LLC | 5 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $136 |
| Amgen Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| Exact Sciences Corporation | 5 | $102 |
Products named: VRAYLAR, VOQUEZNA, STRENSIQ, CAPLYTA, VYEPTI, XIFAXAN, REPATHA, QULIPTA.
Industry payments across NY — which companies pay providers there.
